Cargando…

Recent advances in understanding multiple myeloma

There have been major recent advancements in the understanding and management of multiple myeloma. Diagnostic criteria have been revised and former ultra-high-risk smoldering multiple myeloma is now considered multiple myeloma in need of treatment. Understanding clonal progression, evolution, and ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhakal, Binod, Girnius, Saulius, Hari, Parameswaran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995679/ https://www.ncbi.nlm.nih.gov/pubmed/27610224 http://dx.doi.org/10.12688/f1000research.8777.1

Ejemplares similares

A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics
por: Awada, Hassan, et al.
Publicado: (2021)

Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2022)

Recent advances in understanding and treating immunoglobulin light chain amyloidosis
por: Badar, Talha, et al.
Publicado: (2018)

Recent Advances in the Understanding and Treatment of Multiple Myeloma
por: Cook, Richard, et al.
Publicado: (2008)

Prevalence and Significance of Sarcopenia in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation
por: Williams, Alexis, et al.
Publicado: (2020)

Recent Advances in Nanotherapeutics for Multiple Myeloma
por: Iannazzo, Daniela, et al.
Publicado: (2020)

Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma
por: Pisano, Michael, et al.
Publicado: (2021)

Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study
por: Buradagunta, Christopher Staffi, et al.
Publicado: (2022)

Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma
por: Dhakal, Binod, et al.
Publicado: (2019)

Recent Advances in the Management of Smoldering Multiple Myeloma
por: Madhira, Bhaskara Reddy, et al.
Publicado: (2020)

Recent Advances in the Treatment of Patients with Multiple Myeloma
por: Legarda, Mario A., et al.
Publicado: (2020)

A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy
por: Kleman, Ariel, et al.
Publicado: (2023)

Development of Novel Immunotherapies for Multiple Myeloma
por: Al-Hujaily, Ensaf M., et al.
Publicado: (2016)

Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse
por: Dhakal, Binod, et al.
Publicado: (2022)

Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study
por: Dong, Jing, et al.
Publicado: (2022)

Recent advances in multiple myeloma: a Korean perspective
por: Hong, Junshik, et al.
Publicado: (2016)

Recent advances in understanding multiple sclerosis
por: Stys, Peter K., et al.
Publicado: (2019)

Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma
por: Abramson, Hanley N.
Publicado: (2023)

Recent advances in the treatment of multiple myeloma: a brief review
por: Bobin, Arthur, et al.
Publicado: (2022)

BCMA-targeted CAR-T cell therapies in relapsed and/or refractory multiple myeloma: latest updates from 2023 ASCO Annual Meeting
por: Wu, James F., et al.
Publicado: (2023)

S203: QUADRUPLET INDUCTION THERAPY, ASCT AND MRD-MODULATED CONSOLIDATION AND TREATMENT CESSATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL ANALYSIS OF THE MASTER TRIAL
por: Costa, Luciano, et al.
Publicado: (2023)

CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma
por: Martino, Massimo, et al.
Publicado: (2021)

Recent Advances on the Pathobiology and Treatment of Multiple Myeloma
por: Amodio, Nicola
Publicado: (2021)

Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma
por: Micallef, Johann, et al.
Publicado: (2010)

Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
por: Libby, Edward, et al.
Publicado: (2020)

Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma
por: Hammons, Lindsay R., et al.
Publicado: (2022)

Recent advances in the management of older adults with newly diagnosed multiple myeloma in Japan
por: Suzuki, Tomotaka, et al.
Publicado: (2022)

In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management
por: Rifkin, Robert M., et al.
Publicado: (2023)

Germline Risk Contribution to Genomic Instability in Multiple Myeloma
por: Janz, Siegfried, et al.
Publicado: (2019)

Recent advances in understanding dengue
por: Yacoub, Sophie, et al.
Publicado: (2016)

Recent advances in understanding psoriasis
por: Eberle, Franziska C., et al.
Publicado: (2016)

Recent advances in understanding neutrophils
por: Deniset, Justin F., et al.
Publicado: (2016)

Recent advances in understanding Streptomyces
por: Chater, Keith F.
Publicado: (2016)

Recent advances in understanding vitiligo
por: Manga, Prashiela, et al.
Publicado: (2016)

Recent advances in understanding photosynthesis
por: Flügge, Ulf-Ingo, et al.
Publicado: (2016)

Recent advances in understanding noroviruses
por: Bartnicki, Eric, et al.
Publicado: (2017)

Recent Advances in Understanding Cholangiocarcinoma
por: Kennedy, Lindsey, et al.
Publicado: (2017)

Recent advances in understanding grasslands
por: Stevens, Carly J.
Publicado: (2018)

Recent advances in understanding dengue
por: Halstead, Scott
Publicado: (2019)

Recent advances in understanding spondyloarthritis
por: Gaston, J.S.H.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3n64bt4rumej3u8l7odprpl306